Harnessing the Immune System: PDS Biotech’s NextGen Approach to Cancer Treatment
In this episode of Rx for Biotech, host Chris Leidli sits down with Dr. Frank Bedu-Addo, CEO of PDS Biotechnology, to discuss how the company is reimagining immunotherapy with its proprietary Versamune® T-cell activating platform.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.